MOMarie O'SHea

Marie O'SHea

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marie O'SHea has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RNA interference screen against SARS-CoV-2 identifies proviral vesicular transport factors involved in release

    by Holly E. M. Kerr, Alison Daniels, Sarah L. Fletcher, Nicky Craig, Marie O'SHea, Samantha J. Griffiths, Daniel Sachs, Sophie Donovan, Rennos Fragkoudis, Juergen G. Haas, et al.

    Identifying host factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is paramount to understanding the replication cycle and developing host-targeting antivirals. However, most host factor screens are significantly biassed towards early replication factors and miss the important steps of assembly and release. Here, we present an arrayed, druggable genome RNAi knockdown screen interrogating SARS-CoV-2 replication in human cells using reverse transcription-quantitative polymerase chain reaction quantification of virus production at two timepoints for comprehensive analysis of pro- and antiviral factors across the entire replication and reinfection cycle. Comparative meta-analysis with other screens and genome-wide association studies demonstrated overlap. Pathway analysis and validation confirmed the identification of known and novel key pathways in SARS-CoV-2 infection. A cluster of proviral factors involved in vesicle-mediated exocytic transport was confirmed to be involved in virus production in the ‘European original’ and variants Delta and Omicron. Inhibiting proviral Rab11a-mediated cargo delivery with cyclin-dependent kinase 9 inhibitor-73 prevented SARS-CoV-2 release, highlighting potential new mechanisms of action for host-targeting antivirals.

  • Top Cited Papers
    Open Access

    Feline infectious peritonitis epizootic caused by a recombinant coronavirus

    by Charalampos Attipa, Amanda S. Warr, Demetris Epaminondas, Marie O’sHea, Andrew J. Hanton, Sarah Fletcher, Alexandra Malbon, Maria Lyraki, Rachael Hammond, Alexandros Hardas, et al.

    Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1–3. While the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed4–7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as the susceptibility of these animals to SARS-CoV-29, highlight their importance in potential transmission cycles. While recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a highly pathogenic FCoV–CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP) originating in Cyprus11. The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears to be very frequent and sequence identities of samples from cats in different districts of the island are strongly supportive of direct transmission. A near-cat-specific deletion in the domain 0 of S is present in more than 90% of cats with FIP. It is unclear as yet whether this deletion is directly associated with disease development, and it may be linked to a biotype switch12. The domain 0 deletion and several amino acid changes in S, particularly the receptor-binding domain, indicate potential changes to receptor binding and cell tropism.


  • Open Access

    Emergence and spread of feline infection peritonitis due to a highly pathogenic canine/feline recombinant coronavirus

    by Christine Tait-Burkard, Charalampos Atippa, Amanda Warr, Demetris Epaminondas, Marie O'SHea, Sarah Fletcher, Alexandra Malbon, Maria Lyraki, Rachael Hammond, Alexandros Hardas, et al.

    Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health1-3. Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated4-7. Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E5,8, as well as their susceptibility to SARS-CoV-29 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described5,10, here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus11. The recombination, spanning spike, shows 97% sequence identity to the pantropic canine coronavirus CB/05. Infection is spreading fast and infecting cats of all ages. Development of FIP appears rapid and likely non-reliant on biotype switch12. High sequence identity of isolates from cats in different districts of the island is strongly supportive of direct transmission. A deletion and several amino acid changes in spike, particularly the receptor binding domain, compared to other FCoV-2s, indicate changes to receptor binding and likely cell tropism.


  • Open Access

    Emergence and spread of feline infectious peritonitis due to a highly pathogenic canine/feline recombinant coronavirus

    by Charalampos Attipa, Amanda Susan Warr, Demetris Epaminondas, Marie O’shea, Andrew J Hanton, Sarah Louise Fletcher, Alexandra Malbon, Maria Lyraki, Rachael Hammond, Alexandros Hardas, et al.

    Cross-species transmission of coronaviruses (CoVs) poses a serious threat to both animal and human health 1–3 . Whilst the large RNA genome of CoVs shows relatively low mutation rates, recombination within genera is frequently observed and demonstrated 4–7 . Companion animals are often overlooked in the transmission cycle of viral diseases; however, the close relationship of feline (FCoV) and canine CoV (CCoV) to human hCoV-229E 5,8 , as well as their susceptibility to SARS-CoV-2 9 highlight their importance in potential transmission cycles. Whilst recombination between CCoV and FCoV of a large fragment spanning orf1b to M has been previously described 5,10 , here we report the emergence of a novel, highly pathogenic FCoV-CCoV recombinant responsible for a rapidly spreading outbreak of feline infectious peritonitis (FIP), originating in Cyprus 11 . The minor recombinant region, spanning spike (S), shows 96.5% sequence identity to the pantropic canine coronavirus NA/09. Infection has rapidly spread, infecting cats of all ages. Development of FIP appears very frequent and sequence identities of samples from cats in different districts of the island is strongly supportive of direct transmission. A near cat-specific deletion in the domain 0 of S is present in >90% of FIP cats. It is unclear as yet whether this deletion is directly associated with disease development and may be linked to a biotype switch 12 . The domain 0 deletion and several amino acid changes in S, particularly the receptor binding domain, indicate potential changes to receptor binding and cell tropism.